Patents by Inventor Paul A. Christian

Paul A. Christian has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12013937
    Abstract: A computer system generates a hierarchical evolutionary tree of digests of sample files. The digests are generated using a locality sensitive hashing function. The digests are grouped into several clusters, and the clusters are grouped into several nodes. The nodes are connected in hierarchical order to generate the hierarchical evolutionary tree. A digest of a file being evaluated for malware is generated using the locality sensitive hashing function. The digest is put in a cluster of the hierarchical evolutionary tree having digests that are most similar to the digest relative to digests of other clusters of the hierarchical evolutionary tree. The digest is identified to be of the same malware family as the digests of the cluster.
    Type: Grant
    Filed: July 29, 2021
    Date of Patent: June 18, 2024
    Assignee: Trend Micro Incorporated
    Inventors: Jonathan James Oliver, Chia-Yen Chang, Wen-Kwang Tsao, Joseph Cepe, Maria Estella Manly Reyes, Paul Christian D. Pajares, Jayson Pryde, Chiaming Chiang, Brandon Niemczyk, Leslie Zsohar
  • Patent number: 11988851
    Abstract: Compact lens systems that may be used in small form factor cameras. The lens system may include a master lens with two or more lens elements arranged along an optical axis and having refractive power, and an optical actuator located on the object side of the master lens that may provide autofocus (AF) and/or optical image stabilization (OIS) functionality for the camera. An aperture stop for the camera may be included in the optical actuator, for example between a substrate and a flexible optical element of the optical actuator. Including the aperture stop in the optical actuator rather than in the lens stack may allow the optical actuator to be smaller in the X-Y dimensions (perpendicular to the optical (Z) axis) than it would be in a similar camera with the aperture stop located in the lens stack.
    Type: Grant
    Filed: October 29, 2021
    Date of Patent: May 21, 2024
    Assignee: Apple Inc.
    Inventors: Paul Christian Thomas Fuller, Iain A. McAllister, Yoshikazu Shinohara
  • Patent number: 11984594
    Abstract: Provided are methods of preparing an electrochemically active cathode material including the steps of combining an alkali metal-containing nickel oxide having a formula A1?aNi1+aO2, wherein A comprises an alkali metal and 0<a?0.2, with a fluid composition including an oxidant comprising a peroxydisulfate salt, a monopersulfate salt, or a combination thereof to form a mixture, heating the mixture to a temperature of 50° C. or greater; and maintaining the mixture at the temperature for at least a period of time sufficient to form an alkali metal-deficient nickel oxide electrochemically active cathode material having a general formula AxHyNi1+aO2·nH2O, wherein A comprises an alkali metal; 0.08?x<0.2; 0?y<0.3; 0.02?a?0.2; and 0<n<2.
    Type: Grant
    Filed: January 22, 2021
    Date of Patent: May 14, 2024
    Assignee: DURACELL U.S. OPERATIONS, INC.
    Inventors: Fan Zhang, Paul A. Christian, Jennifer A. Nelson, David L. Anglin, Paul Wildgust, Thomas Baccaro
  • Publication number: 20240101561
    Abstract: This invention relates to tetrazoles and their use as inhibitors of TRPA1 activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of fibrotic diseases, inflammatory and auto-immune diseases and CNS-related diseases.
    Type: Application
    Filed: October 14, 2020
    Publication date: March 28, 2024
    Inventors: Martin Thomas FLECK, Florian Paul Christian BINDER, Georg DAHMANN, Joerg P. HEHN, Uta Friederike LESSEL, Jens WILLWACHER
  • Publication number: 20240092769
    Abstract: This invention relates to novel (Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles and their use as CB2 cannabinoid receptor agonists, pharmaceutical compositions containing the same, and their use for the treatment of CB2 receptor mediated disorders or conditions.
    Type: Application
    Filed: June 30, 2023
    Publication date: March 21, 2024
    Inventors: Doris Riether, Florian Paul Christian Binder, Henri Doods, Stephan George Mueller, Janet Rachel Nicholson, Achim Sauer
  • Publication number: 20240059675
    Abstract: The present disclosure provides certain piperidinylpyridinylcarbonitrile derivatives, and pharmaceutically acceptable salts thereof, that are inhibitors of Glutaminyl-peptide cyclotransferase (QPCT) and glutaminyl-peptide cyclotransferase-like protein (QPCTL), and are therefore useful for the treatment of diseases treatable by inhibition of QPCT/L. Also provided are pharmaceutical compositions containing the same, and processes for preparing said compounds.
    Type: Application
    Filed: July 31, 2023
    Publication date: February 22, 2024
    Inventors: Jens WILLWACHER, Florian Paul Christian BINDER, Georg DAHMANN, James Young Soo YANG HAMILTON, Sandra Ruth HANDSCHUH, Sophia Astrid REINDL
  • Patent number: 11909126
    Abstract: Systems, apparatuses and methods provides for technology that generates, with a phased array of elements of an antenna system, an array element radiation pattern over a scan angle range, where the phased array of elements is spaced at a predetermined wavelength spacing. The technology reflects, with a reflector of the antenna system, the array element radiation pattern emitted from the phased array of elements to Earth, and establishes, based on a shape of the reflector, a predetermined magnification as a function of scan angle range so as to increase the field-of-view of the antenna system. The technology adjusts, based on the shape of the reflector, the array element radiation pattern, by increasing magnification relative to the scan angle range, to have a gain that increases with increases in scan angle relative to a boresight of the antenna system, and reflects, with the reflector, radiation from Earth to the phased array of elements.
    Type: Grant
    Filed: December 17, 2021
    Date of Patent: February 20, 2024
    Assignee: The Boeing Company
    Inventors: Paul Christian Werntz, Raenaurd Turpin, Daniel Francis Mathews, Charles Youngshiuk Park
  • Patent number: 11891403
    Abstract: The present disclosure provides certain tetrazole derivatives that are inhibitors of transient receptor potential ankyrin 1 (TRPA1), and are therefore useful for the treatment of diseases treatable by inhibition of TRPA1. Also provided are pharmaceutical compositions containing the same, and processes for preparing said compounds.
    Type: Grant
    Filed: June 24, 2021
    Date of Patent: February 6, 2024
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Martin Thomas Fleck, Florian Paul Christian Binder, Jens Willwacher
  • Patent number: 11884652
    Abstract: The present disclosure provides certain tetrazole derivatives that are inhibitors of transient receptor potential ankyrin 1 (TRPA1), and are therefore useful for the treatment of diseases treatable by inhibition of TRPA1. Also provided are pharmaceutical compositions containing the same, and processes for preparing said compounds.
    Type: Grant
    Filed: June 24, 2021
    Date of Patent: January 30, 2024
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Florian Paul Christian Binder, Martin Thomas Fleck, Jens Willwacher
  • Patent number: 11884681
    Abstract: The present disclosure provides certain 3H,4H,5H,6H,7H-pyrimido[4,5-b][1,4]oxazine-4,6-dione derivatives that are inhibitors of transient receptor potential ankyrin 1 (TRPA1), and are therefore useful for the treatment of diseases treatable by inhibition of TRPA1. Also provided are pharmaceutical compositions containing the same, and processes for preparing said compounds.
    Type: Grant
    Filed: April 13, 2022
    Date of Patent: January 30, 2024
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Martin Thomas Fleck, Florian Paul Christian Binder
  • Patent number: 11878981
    Abstract: The present disclosure provides certain substituted 1,2,4-oxadiazole derivatives of the below formula (I) that are inhibitors of transient receptor potential ankyrin 1 (TRPA1), and are therefore useful for the treatment of diseases treatable by inhibition of TRPA1. Also provided are pharmaceutical compositions containing the same, and processes for preparing said compounds.
    Type: Grant
    Filed: April 13, 2022
    Date of Patent: January 23, 2024
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Florian Paul Christian Binder, Georg Dahmann, Martin Thomas Fleck, Annekatrin Charlotte Heimann, Thorsten Oost
  • Patent number: 11858921
    Abstract: The present disclosure provides certain uracil derivatives that are inhibitors of transient receptor potential ankyrin 1 (TRPA1), and are therefore useful for the treatment of diseases treatable by inhibition of TRPA1. Also provided are pharmaceutical compositions containing the same, and processes for preparing said compounds.
    Type: Grant
    Filed: April 13, 2022
    Date of Patent: January 2, 2024
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Florian Paul Christian Binder, Martin Thomas Fleck, Jens Willwacher
  • Publication number: 20230257395
    Abstract: The present disclosure provides certain tetrazole derivatives that are inhibitors of transient receptor potential ankyrin 1 (TRPA1), and are therefore useful for the treatment of diseases treatable by inhibition of TRPA1. Also provided are pharmaceutical compositions containing the same, and processes for preparing said compounds.
    Type: Application
    Filed: April 19, 2023
    Publication date: August 17, 2023
    Inventors: Florian Paul Christian BINDER, Thomas Martin FLECK, Jens WILLWACHER
  • Patent number: 11725004
    Abstract: This invention relates to novel (Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles and their use as CB2 cannabinoid receptor agonists, pharmaceutical compositions containing the same, and their use for the treatment of CB2 receptor mediated disorders or conditions.
    Type: Grant
    Filed: August 10, 2021
    Date of Patent: August 15, 2023
    Assignee: Centrexion Therapeutics Corporation
    Inventors: Doris Riether, Florian Paul Christian Binder, Henri Doods, Stephan Georg Mueller, Janet Rachel Nicholson, Achim Sauer
  • Patent number: 11724889
    Abstract: A nip guard (10) for use with a conveyor system which includes a pulley (84) and a flexible conveyor belt (88) which is engaged with and which passes over the pulley (84), the conveyor belt (88) including an outer load-carrying surface (82) and an inner surface (86), wherein the nip guard (10) includes supporting structure (64, 66, 60) and, mounted to the supporting structure (60, 64, 66), at least one belt scraping element (46) configured to be in scraping contact with the inner surface (86) of the belt (88).
    Type: Grant
    Filed: April 15, 2020
    Date of Patent: August 15, 2023
    Assignee: Brelko Patents (Pty) Ltd
    Inventors: Jacques Marais, Paul Christian
  • Patent number: 11721894
    Abstract: A near-field test system for a phased array antenna includes a probe, a beam forming network, and a computing system. The probe is disposed at a fixed position in a near-field of the phased array antenna and transmits a test beam toward a fixed location on the phased array. The beam forming network is coupled to the phased array and includes a plurality of phase shifters and a beam summer. The phase shifters steer received beams for each antenna element of the phased array to form a planar wave front. The beam summer is coupled to the phase shifters and combines power of the received beams. The computing system is coupled to the beam forming network and scales combined power of the received beams and generates a virtual spectrum for the phased array antenna from scaled power of the received beams.
    Type: Grant
    Filed: April 3, 2020
    Date of Patent: August 8, 2023
    Assignee: The Boeing Company
    Inventors: Carl J. Hahn, III, Jeffrey T. McCollam, Paul Christian Werntz
  • Publication number: 20230198142
    Abstract: Systems, apparatuses and methods provides for technology that generates, with a phased array of elements of an antenna system, an array element radiation pattern over a scan angle range, where the phased array of elements is spaced at a predetermined wavelength spacing. The technology reflects, with a reflector of the antenna system, the array element radiation pattern emitted from the phased array of elements to Earth, and establishes, based on a shape of the reflector, a predetermined magnification as a function of scan angle range so as to increase the field-of-view of the antenna system. The technology adjusts, based on the shape of the reflector, the array element radiation pattern, by increasing magnification relative to the scan angle range, to have a gain that increases with increases in scan angle relative to a boresight of the antenna system, and reflects, with the reflector, radiation from Earth to the phased array of elements.
    Type: Application
    Filed: December 17, 2021
    Publication date: June 22, 2023
    Applicant: The Boeing Company
    Inventors: Paul Christian WERNTZ, Raenaurd TURPIN, Daniel Francis MATHEWS, Charles Youngshiuk PARK
  • Patent number: 11661430
    Abstract: The present disclosure provides certain tetrazole derivatives that are inhibitors of transient receptor potential ankyrin 1 (TRPA1), and are therefore useful for the treatment of diseases treatable by inhibition of TRPA1. Also provided are pharmaceutical compositions containing the same, and processes for preparing the same.
    Type: Grant
    Filed: October 13, 2021
    Date of Patent: May 30, 2023
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Florian Paul Christian Binder, Thomas Martin Fleck, Jens Willwacher
  • Patent number: 11661427
    Abstract: The present disclosure provides certain tetrazole derivatives that are inhibitors of transient receptor potential ankyrin 1 (TRPA1), and are therefore useful for the treatment of diseases treatable by inhibition of TRPA1. Also provided are pharmaceutical compositions containing the same, and processes for preparing the same.
    Type: Grant
    Filed: October 13, 2021
    Date of Patent: May 30, 2023
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Martin Thomas Fleck, Florian Paul Christian Binder, Jens Willwacher
  • Patent number: 11578080
    Abstract: This invention relates to thienopyrimidinones and their use as inhibitors of TRPA1 activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of fibrotic diseases, inflammatory and auto-immune diseases and CNS-related diseases.
    Type: Grant
    Filed: September 1, 2021
    Date of Patent: February 14, 2023
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Martin Thomas Fleck, Florian Paul Christian Binder, Georg Dahmann, Joerg P. Hehn, Annekatrin Charlotte Heimann, Uta Friederike Lessel, Jens Willwacher